1. Home
  2. FRMM vs ANVS Comparison

FRMM vs ANVS Comparison

Compare FRMM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMM

Forum Markets Incorporated Common Stock

N/A

Current Price

$5.80

Market Cap

65.8M

Sector

Health Care

ML Signal

N/A

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.96

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRMM
ANVS
Founded
N/A
2008
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
69.1M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
FRMM
ANVS
Price
$5.80
$1.96
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$13.50
AVG Volume (30 Days)
319.0K
905.0K
Earning Date
05-26-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$183.55
N/A
Revenue Next Year
$166.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$1.54
52 Week High
$7.15
$5.50

Technical Indicators

Market Signals
Indicator
FRMM
ANVS
Relative Strength Index (RSI) 55.97 55.50
Support Level $4.78 $1.92
Resistance Level N/A $2.07
Average True Range (ATR) 0.60 0.12
MACD 0.04 0.03
Stochastic Oscillator 43.09 58.10

Price Performance

Historical Comparison
FRMM
ANVS

About FRMM Forum Markets Incorporated Common Stock

Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: